Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of HPV High-risk Infection

NCT06610773 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06610773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of HPV High-risk Infection
Lead sponsor
Shanghai East Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
September 10, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus viruses, mesenchymal stem cells